Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Roche YTD11 | Contract Pharma

What are you searching for?

Sign in
Breaking News

Financial Report: Roche YTD11

Foreign exchange hurts results

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

YTD Revenues: 31.5 billion (-13%)

Comments: Group sales were down -12%, excluding Tamiflu. Pharmaceutical sales were 24.4 billion (-14%). Herceptin sales were up +8% and MabThera/Rituxan, up +7%. Lucentis sales were up 26%. Actemra sales jumped +86%. Professional Diagnostics business revenues were up 9%. Foreign exchange negatively impacted results by -13% due to appreciation of the Swiss franc.

All numbers reported in CHF

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters